GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » Inventories, Finished Goods

Bullfrog AI Holdings (Bullfrog AI Holdings) Inventories, Finished Goods : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings Inventories, Finished Goods?


Bullfrog AI Holdings Inventories, Finished Goods Historical Data

The historical data trend for Bullfrog AI Holdings's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bullfrog AI Holdings Inventories, Finished Goods Chart

Bullfrog AI Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Finished Goods
- - - -

Bullfrog AI Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bullfrog AI Holdings Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Traded in Other Exchanges
N/A
Address
325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
Executives
William Enright director 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey director 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio officer: Chief Financial Officer
Jason David Hanson director 8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh director, 10 percent owner, officer: Chief Executive Officer 4 BLACK KETTLE COURT, BOYDS MD 20841